Avior Wealth Management LLC trimmed its holdings in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Free Report) by 50.4% during the second quarter, HoldingsChannel reports. The institutional investor owned 12,070 shares of the company’s stock after selling 12,254 shares during the quarter. Avior Wealth Management LLC’s holdings in SPDR S&P Pharmaceuticals ETF were worth $800,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently modified their holdings of XPH. Turtle Creek Wealth Advisors LLC purchased a new position in SPDR S&P Pharmaceuticals ETF in the 1st quarter worth approximately $26,000. Western Wealth Management LLC acquired a new position in SPDR S&P Pharmaceuticals ETF in the first quarter worth $34,000. Advisory Services Network LLC bought a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 3rd quarter valued at about $34,000. Fifth Third Bancorp bought a new position in shares of SPDR S&P Pharmaceuticals ETF during the first quarter valued at approximately $39,000. Finally, Kestra Advisory Services LLC bought a new position in SPDR S&P Pharmaceuticals ETF during the 4th quarter worth $151,000.
SPDR S&P Pharmaceuticals ETF Stock Up 0.3%
XPH stock opened at $70.52 on Friday. The firm’s 50-day simple moving average is $65.00 and its 200 day simple moving average is $59.46. SPDR S&P Pharmaceuticals ETF has a fifty-two week low of $42.63 and a fifty-two week high of $71.13. The stock has a market cap of $507.74 million, a PE ratio of 14.28 and a beta of 0.58.
SPDR S&P Pharmaceuticals ETF Profile
SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
See Also
- Five stocks we like better than SPDR S&P Pharmaceuticals ETF
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Want to see what other hedge funds are holding XPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Free Report).
Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
